December 1, 2016 - By Darrin Black · 0 Comments
The stock of DAIICHI SANKYO COMPANY LIGHT (OTCMKTS:DSKYF) registered a decrease of 14.01% in short interest. DSKYF’s total short interest was 1.50M shares in December as published by FINRA. Its down 14.01% from 1.75M shares, reported previously. With 200 shares average volume, it will take short sellers 7517 days to cover their DSKYF’s short positions. The stock closed at $21.59 during the last session. It is up 8.71% since April 28, 2016 and is downtrending. It has underperformed by 14.64% the S&P500.
More notable recent DAIICHI SANKYO COM NPV (OTCMKTS:DSKYF) news were published by: Seekingalpha.com which released: “Daiichi Sankyo’s Factor Xa Inhibitor Edoxaban Clears Phase III Hurdle – A …” on November 21, 2013, also Seekingalpha.com with their article: “When Can Portola’s Drug Be Approved, And How Much Does It Matter?” published on August 24, 2016, Seekingalpha.com published: “Portola Pharmaceuticals: Undervalued Because Investors Underestimate The …” on November 03, 2015. More interesting news about DAIICHI SANKYO COM NPV (OTCMKTS:DSKYF) were released by: Seekingalpha.com and their article: “Latest Tivantinib Failure Hits ArQule Despite Its Irrelevance” published on January 15, 2013 as well as Investorideas.com‘s news article titled: “Biotech Stock Directory Update” with publication date: August 14, 2014.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Darrin Black